drugset / Trial / NCT00883870

Mesenchymal Stem Cells in Critical Limb Ischemia

NCT00883870

Phase 1/2 Completed 20 enrolled Stempeutics Research Pvt Ltd
RandomizedParallel-groupTriple-blindTreatment

Summary

This clinical trial aims to study the safety and efficacy of adult mesenchymal stem cells in critical limb ischemia.

Timeline

Start
2009-04
Primary completion
2010-02
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 2e+06 cells/kg Intramuscular

Indications